Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Houdusse

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Cell|October 9, 2020
Single Residue Variation in Skeletal Muscle Myosin Enables Direct and Selective Drug Targeting for Spasticity and Muscle StiffnessMáté Gyimesi, Ádám I Horváth, Demeter Túrós, et al.
Developmental Cell|October 24, 2023
MiniBAR/GARRE1 is a dual Rac and Rab effector required for ciliogenesisMurielle P Serres, Ronan Shaughnessy, Sophie Escot, et al.
Nature Cardiovascular Research|August 28, 2024
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathyJames J Hartman, Darren T Hwee, Julien Robert-Paganin, et al.
Chembiochem : a European Journal of Chemical Biology|February 26, 2019
2nd PSL Chemical Biology Symposium (2019): At the Crossroads of Chemistry and BiologyMarco Lucchino, Anne Billet, Antoine Versini, et al.
Nature Communications|October 23, 2023
How myosin VI traps its off-state, is activated and dimerizesLouise Canon, Carlos Kikuti, Vicente J Planelles-Herrero, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic PotentialLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
Cell|July 2, 2025
Development of clinically viable non-muscle myosin II small molecule inhibitorsLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Cell|October 9, 2020
Single Residue Variation in Skeletal Muscle Myosin Enables Direct and Selective Drug Targeting for Spasticity and Muscle StiffnessMáté Gyimesi, Ádám I Horváth, Demeter Túrós, et al.
Developmental Cell|October 24, 2023
MiniBAR/GARRE1 is a dual Rac and Rab effector required for ciliogenesisMurielle P Serres, Ronan Shaughnessy, Sophie Escot, et al.
Nature Cardiovascular Research|August 28, 2024
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathyJames J Hartman, Darren T Hwee, Julien Robert-Paganin, et al.
Chembiochem : a European Journal of Chemical Biology|February 26, 2019
2nd PSL Chemical Biology Symposium (2019): At the Crossroads of Chemistry and BiologyMarco Lucchino, Anne Billet, Antoine Versini, et al.
Nature Communications|October 23, 2023
How myosin VI traps its off-state, is activated and dimerizesLouise Canon, Carlos Kikuti, Vicente J Planelles-Herrero, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic PotentialLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
Cell|July 2, 2025
Development of clinically viable non-muscle myosin II small molecule inhibitorsLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.
Pageof 10